Tofacitinib for hospitalized acute severe Ulcerative Colitis – the TRIUMPH studyECCO'24 Stockholm
2024
Topical Sphingosine-1-Phosphate (S1P) Receptor 1 Modulation Regulates Gut Angiogenesis in Inflammatory Bowel DiseasesECCO'24 Stockholm
2024
Transcriptomic signature of response to vedolizumab in patients with moderate-to-severe ulcerative colitis: Results from an international, multicentre, retrospective cohort studyECCO'24 Stockholm
2024
TWIST1-mediated fibroblast activation protein (FAP)-expressing fibroblasts drives fibrosis in Crohn’s DiseaseECCO'24 Stockholm
2024
Up-regulated Gremlin 1 in fibroblasts from Crohn’s Disease fibrotic strictures: A potential therapeutic targetECCO'24 Stockholm
2024
Vedolizumab response in ulcerative colitis associates with reduced IgG+ plasma cells and FcγR signalingECCO'24 Stockholm
2024
Yield of surveillance colonoscopy in patients with Primary Sclerosing CholangitisECCO'24 Stockholm
2024
ECCO'22:
2022